» Articles » PMID: 23021982

Eph/Ephrin Signaling in Injury and Inflammation

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2012 Oct 2
PMID 23021982
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

The Eph/ephrin receptor-ligand system plays an important role in embryogenesis and adult life, principally by influencing cell behavior through signaling pathways, resulting in modification of the cell cytoskeleton and cell adhesion. There are 10 EphA receptors, and six EphB receptors, distinguished on sequence difference and binding preferences, that interact with the six glycosylphosphatidylinositol-linked ephrin-A ligands and the three transmembrane ephrin-B ligands, respectively. The Eph/ephrin proteins, originally described as developmental regulators that are expressed at low levels postembryonically, are re-expressed after injury to the optic nerve, spinal cord, and brain in fish, amphibians, rodents, and humans. In rodent spinal cord injury, the up-regulation of EphA4 prevents recovery by inhibiting axons from crossing the injury site. Eph/ephrin proteins may be partly responsible for the phenotypic changes to the vascular endothelium in inflammation, which allows fluid and inflammatory cells to pass from the vascular space into the interstitial tissues. Specifically, EphA2/ephrin-A1 signaling in the lung may be responsible for pulmonary inflammation in acute lung injury. A role in T-cell maturation and chronic inflammation (heart failure, inflammatory bowel disease, and rheumatoid arthritis) is also reported. Although there remains much to learn about Eph/ephrin signaling in human disease, and specifically in injury and inflammation, this area of research raises the exciting prospect that novel therapies will be developed that precisely target these pathways.

Citing Articles

Perturbation of EPHA2 and EFNA1 binding amplifies inflammatory response in airway epithelial cells.

Fukuda R, Beppu S, Hinata D, Kamada Y, Okiyoneda T iScience. 2025; 28(2):111872.

PMID: 39991543 PMC: 11847143. DOI: 10.1016/j.isci.2025.111872.


Plasma EphA2 level is a superior biomarker to Del-1 for sepsis diagnosis and prognosis.

Lee E, Shin M, Kwak S, Choi J, Leem A, Lee S Front Med (Lausanne). 2025; 12:1505882.

PMID: 39926431 PMC: 11802418. DOI: 10.3389/fmed.2025.1505882.


Identification of Inflammatory Gene in the Congenital Heart Surgery Patients following Cardiopulmonary Bypass via the Way of WGCNA and Machine Learning Algorithms.

Cai L, Zhang B Dis Markers. 2024; 2023:5493415.

PMID: 39281206 PMC: 11401684. DOI: 10.1155/2023/5493415.


Protective effect of the total alkaloid extract from Bulbus on cigarette smoke-induced Beas-2B cell injury model and transcriptomic analysis.

Wang X, Liu X, Aga E, Tse W, Tse K, Ye B Food Nutr Res. 2024; 68.

PMID: 38974914 PMC: 11227262. DOI: 10.29219/fnr.v68.10689.


The landscape of rare genetic variation associated with inflammatory bowel disease and Parkinson's disease comorbidity.

Kars M, Wu Y, Stenson P, Cooper D, Burisch J, Peter I Genome Med. 2024; 16(1):66.

PMID: 38741190 PMC: 11092054. DOI: 10.1186/s13073-024-01335-2.